Webinar | Nestlé and Arla are leading GLP-1 food innovation. Is your R&D keeping up?​ Register Now

Akrivia Biomedics

Akrivia Biomedics develops biology-driven molecular diagnostics to guide personalized cancer treatment and improve therapy decisions.
2019
11-50
London, England, United Kingdom
  • Drug Discovery and Development
  • Oncology (Cancer)
  • Pathology & Diagnostics
  • Personalized Medicine Technologies

Investment Funding

Revenue

$1M to $10M

Something missing or incorrect on this page? Help us enrich this information